Effect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from a Phase IIIb Trial

dc.contributor.authorLancaster, L. H.
dc.contributor.authorConoscenti, C. S.
dc.contributor.authorIlowite, J.
dc.contributor.authorTrampisch, M.
dc.contributor.authorMogulkoc, N.
dc.contributor.authorHomik, L.
dc.contributor.authorKaye, M.
dc.date.accessioned2019-10-27T10:44:48Z
dc.date.available2019-10-27T10:44:48Z
dc.date.issued2018
dc.departmentEge Üniversitesien_US
dc.descriptionInternational Conference of the American-Thoracic-Society -- MAY 18-23, 2018 -- San Diego, CAen_US
dc.description.sponsorshipAmer Thoracic Socen_US
dc.description.sponsorshipBoehringer IngelheimBoehringer Ingelheimen_US
dc.description.sponsorshipThis abstract is funded by: Boehringer Ingelheimen_US
dc.identifier.issn1073-449X
dc.identifier.issn1535-4970
dc.identifier.urihttps://hdl.handle.net/11454/31042
dc.identifier.volume197en_US
dc.identifier.wosWOS:000449978905337en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Thoracic Socen_US
dc.relation.ispartofAmerican Journal of Respiratory and Critical Care Medicineen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEffect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from a Phase IIIb Trialen_US
dc.typeConference Objecten_US

Dosyalar